MOTIV8 - Treatment Motivation in Forensic Youth Treatment

NCT06474156 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-06-25

No results posted yet for this study

Summary

This project entails to gain a deeper understanding of the development of treatment motivation over the course of intramural and outpatient forensic youth care. Research questions are 1) How does treatment motivation of youth and parents develop over the course of forensic systemic therapy, and following the transition from inpatient to outpatient therapy?; 2) Which client factors, interpersonal factors, and contextual characteristics moderate the development of treatment motivation?; 3) Which mechanisms play a role in the development of treatment motivation?; and 4) How does treatment motivation affect treatment retention and the achievement of primary therapy goals?

Conditions

  • Motivation

Interventions

BEHAVIORAL

Multidimensional Family Therapy

Multidimensional family therapy is a manualized,evidence-based, intensive intervention program with assessment and treatment modules focusing on four areas: (a) the individual adolescents' issues regarding substance use disorder, delinquency, and comorbid psychopathology, (b) the parents' child-rearing skills and personal functioning, (c) communication and relationship between adolescent and parent(s), and (d) interactions between family members and key social systems (Liddle, 2002).

Sponsors & Collaborators

  • Kwaliteit Forensische Zorg Jeugd

    collaborator UNKNOWN
  • University of Amsterdam

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-05
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06474156 on ClinicalTrials.gov